ISTA Pharmaceuticals (ISTA) Tops Q3 EPS by 3c; Guides In-line for FY Revenues
ISTA Hot Sheet
EPS Growth %: +78.6%Financial Fact:
Gross profit: 36.28M
Today's EPS Names:
TARO, BRLI, TLB, More
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) reports Q3 EPS of $0.00 (ex-items) vs. the analyst estimate of ($0.01). Revenue for the quarter was $32.0 million, which compares to the estimate of $27.63 million.
For FY:
Net product revenue for ISTA's four marketed products for the full-year 2009 now is expected to be $103 to $106 million. (consensus is $103.69 million);
ISTA expects to be approximately operating income breakeven in 2009; Full-year 2009 gross margin guidance has been increased to 73% to 75%; Full-year 2009 research and development expenses are now expected to be approximately $23 to $26 million; ISTA expects its net loss for 2009 (excluding any mark-to-market valuation adjustments relating to warrants issued in 2008) will be approximately $7 to $10 million, as its increased net revenue will offset the costs associated with launching Bepreve and expanding its sales force; and ISTA now expects to end 2009 with a cash balance of $45 to $55 million, including cash drawn on its Silicon Valley Bank Revolving Credit Facility.
For FY:
Net product revenue for ISTA's four marketed products for the full-year 2009 now is expected to be $103 to $106 million. (consensus is $103.69 million);
ISTA expects to be approximately operating income breakeven in 2009; Full-year 2009 gross margin guidance has been increased to 73% to 75%; Full-year 2009 research and development expenses are now expected to be approximately $23 to $26 million; ISTA expects its net loss for 2009 (excluding any mark-to-market valuation adjustments relating to warrants issued in 2008) will be approximately $7 to $10 million, as its increased net revenue will offset the costs associated with launching Bepreve and expanding its sales force; and ISTA now expects to end 2009 with a cash balance of $45 to $55 million, including cash drawn on its Silicon Valley Bank Revolving Credit Facility.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Signet Jewelers (SIG) Tops Q1 EPS by 5c; Guides Q2 Below the Street
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
